Profile of microRNAs associated with coronary heart disease in patients with type 2 diabetes
Authors:
- Teona A ShvangiradzeTSTeona A Shvangiradze
- Ekaterina A TroshinaETEkaterina A Troshina
- Alexander V IlyinAIAlexander V Ilyin
- Aleksandr V KarpukhinAKAleksandr V Karpukhin
- Tat'YAna A MuzaffarovaTMTat'YAna A Muzaffarova
- Kristina A GrishinaKGKristina A Grishina
- Anna Yu KuzevanovaAKAnna Yu Kuzevanova
Open Access
- 29 December 2016
- journal article
- Published by Endocrinology Research Centre in Obesity and metabolism
- Vol. 13 (4) , 34-38
Abstract
Introduction. Cardiovascular disease (CVD) remain the leading cause of death in industrialized countries. Patients with coronary heart disease (CHD) in combination with diabetes mellitus type 2 (T2DM) are characterized by more severe CHD and poor prognosis. Resent data indicate microRNAs (miRNAs) as important participants in the pathogenesis of various pathological conditions, including obesity, T2DM and CVD.The aim of this study was to determine expression of miRNAs associated with the development of CHD, and transforming growth factor beta (TGF-β) in a patients with T2DM and obesity Materials and methods. 42 patients with 1-2 degrees obesity and diagnosed T2DM were divided into 2 groups. The first group with CHD, the second group - without CHD. 9 miRNAs were evaluated: miRNA-1, miRNA-21, miRNA-26a, m miRNA-27, miRNA-33a, miRNA-33b, miRNA-133a, miRNA-133b, miRNA-208.Results and discussion. Significant differences were found in expression of miRNA-21, miRNA-26a, miRNA27a. An increased expression of miRNA-21, miRNA-27a was found in patients CHD while the expression of miRNA-26a was reduced in comparison with the group without CHD.Conclusion. The results of this study may be an initial step for the detection of molecular basis in CHD pathogenesis in these patients by quantifying miRNA expression. Introduction. Cardiovascular disease (CVD) remain the leading cause of death in industrialized countries. Patients with coronary heartdisease (CHD) in combination with diabetes mellitus type 2 (T2DM) are characterized by more severe CHD and poor prognosis. Resent data indicate microRNAs (miRNAs) as important participants in the pathogenesis of various pathological conditions, including obesity, T2DM and CVD.The aim of this study was to determine expression of miRNAs associated with the development of CHD, and transforming growth factor beta (TGF-β) in a patients with T2DM and obesity Materials and methods. 42 patients with 1-2 degrees obesity and diagnosed T2DM were divided into 2 groups. The first group with CHD, the second group - without CHD. 9 miRNAs were evaluated: miRNA-1, miRNA-21, miRNA-26a, m miRNA-27, miRNA-33a, miRNA-33b, miRNA-133a, miRNA-133b, miRNA-208.Results and discussion. Significant differences were found in expression of miRNA-21, miRNA-26a, miRNA27a. An increased expression of miRNA-21, miRNA-27a was found in patients CHD while the expression of miRNA-26a was reduced in comparison with the group without CHD.Conclusion. The results of this study may be an initial step for the detection of molecular basis in CHD pathogenesis in these patients by quantifying miRNA expression.Keywords
This publication has 13 references indexed in Scilit:
- MiRNAs in the diagnosis of cardiovascular diseases associated with type 2 diabetes mellitus and obesityTerapevticheskii arkhiv, 2016
- Role of microRNA in oncogenesis of pituitary tumors and their practical significanceTerapevticheskii arkhiv, 2016
- Interaction between microRNA expression and classical risk factors in the risk of coronary heart diseaseScientific Reports, 2015
- MicroRNA-27a decreases the level and efficiency of the LDL receptor and contributes to the dysregulation of cholesterol homeostasisAtherosclerosis, 2015
- MicroRNAs and Cardiovascular DiseasesBioMed Research International, 2015
- Diagnosis, Prognosis and Therapeutic Role of Circulating miRNAs in Cardiovascular DiseasesHeart, Lung and Circulation, 2014
- MicroRNA-21 is a unique signature associated with coronary plaque instability in humans by regulating matrix metalloproteinase-9 via reversion-inducing cysteine-rich protein with Kazal motifsExperimental and Molecular Pathology, 2014
- miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular StudyAtherosclerosis, 2011
- Short Communication: Asymmetric Dimethylarginine Impairs Angiogenic Progenitor Cell Function in Patients With Coronary Artery Disease Through a MicroRNA-21–Dependent MechanismCirculation Research, 2010
- MicroRNA Expression Signature and Antisense-Mediated Depletion Reveal an Essential Role of MicroRNA in Vascular Neointimal Lesion FormationCirculation Research, 2007